Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Current Taxes (2017 - 2019)

Historic Current Taxes for Avalo Therapeutics (AVTX) over the last 3 years, with Q4 2019 value amounting to $551671.0.

  • Avalo Therapeutics' Current Taxes fell 7285.43% to $551671.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $551671.0, marking a year-over-year decrease of 7285.43%. This contributed to the annual value of $551671.0 for FY2019, which is 7285.43% down from last year.
  • Latest data reveals that Avalo Therapeutics reported Current Taxes of $551671.0 as of Q4 2019, which was down 7285.43% from $1.0 million recorded in Q3 2019.
  • Avalo Therapeutics' 5-year Current Taxes high stood at $3.2 million for Q3 2017, and its period low was $551671.0 during Q4 2019.
  • Moreover, its 3-year median value for Current Taxes was $2.1 million (2018), whereas its average is $1.9 million.
  • Its Current Taxes has fluctuated over the past 5 years, first plummeted by 1004.32% in 2018, then crashed by 7285.43% in 2019.
  • Quarter analysis of 3 years shows Avalo Therapeutics' Current Taxes stood at $2.3 million in 2017, then dropped by 10.04% to $2.0 million in 2018, then crashed by 72.85% to $551671.0 in 2019.
  • Its Current Taxes was $551671.0 in Q4 2019, compared to $1.0 million in Q3 2019 and $1.4 million in Q2 2019.